CC

Chiat Chew

Invion Limited | Chief Executive Officer, Executive Chairman, Executive Director
Mr Chew has over 25 years of experience in healthcare biotech, investing and transforming business operations. He is also Co-Founder of Chronic Airway Therapeutics; a clinical stage firm focused on the treatment of respiratory diseases and Managing Partner at Polar Ventures. Thian is also an Advisory Board Member at Stanford Medicine's Center for Asian Health Research and Education (CARE). Prior to this, Thian was an Executive Director at Goldman Sachs (New York, Hong Kong), responsible for the firm's proprietary investments, and was a Consultant Project Manager at Morgan Stanley's Strategic Services Group (New York). He also held several positions in KPMG across Asia Pacific including Director at KPMG Consulting (Singapore and Sydney) where he led several large-scale operational restructurings, post-merger integration, transformation, and business performance improvement programs. As a Senior Manager at KPMG (Taipei and Melbourne), he led several business re-engineering initiatives, and performed financial and information technology audit, risk and assurance engagements across multiple industries. He is also Visiting Professor at UCL Global Business School for Health.

Company and Roles

Company
Title
Tenure
Since
IVX
Invion Limited
  • Chief Executive Officer
  • Executive Chairman
  • Executive Director
8yrs, 6mthDec 2017

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
IVX
Invion Limited
20/04/26246,70610,957,21514,430,944N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
IVX
Invion Limited
20/04/26
Buy
5,488,637$0.061$334,806As advised by the company
IVX
Invion Limited
23/09/25
Expiry
1,384,886$0.110$152,337Options expired
IVX
Invion Limited
23/07/25
Issued
10,000,000$0.015$150,000Rights issue
IVX
Invion Limited
18/07/25
Issued
4,210,806$0.015$63,162Rights issue
IVX
Invion Limited
24/06/25
Exercise
68,086$0.125$8,510Exercise of options